1.
Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416.(Clinical report)
by Honda, Miki
Archives of Ophthalmology, March, 2011, Vol.129(3), p.317(5)
2.
Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats.
by Okuda, Keiji
PloS one, 2016, Vol.11(8), p.e0160944
3.
Polycation liposomes as a vector for potential intracellular delivery of microRNA
by Ando, Hidenori
The journal of gene medicine, October 2013, Vol.15(10), pp.375-83
4.
Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers: chemical structure, morphology, and gene transfer activity.
by Dewa, Takehisa
Bioconjugate chemistry, May 19, 2010, Vol.21(5), pp.844-852
5.
Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity.
by Fukuta, Tatsuya
Scientific reports, July 21, 2016, Vol.6, p.30127
6.
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
by Takahama, Hiroyuki
Cardiovascular drugs and therapy, April 2013, Vol.27(2), pp.125-132
7.
Liposomes and nanotechnology in drug development: focus on ocular targets.
by Honda, Miki
International journal of nanomedicine, 2013, Vol.8, pp.495-503
8.
[In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
by Ando, Hidenori
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Vol.132(12), pp.1373-1381
9.
[Positron emission tomography (PET) imaging of small interfering RNA (siRNA) delivery in drug development].
by Asai, Tomohiro
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Vol.132(10), pp.1159-1163
10.
Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
by Asai, Tomohiro
Bioconjugate chemistry, March 16, 2011, Vol.22(3), pp.429-435
11.
Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced.
by Ishii, Takayuki
Biochemical and biophysical research communications, January 25, 2013, Vol.430(4), pp.1201-1205
12.
Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
by Fukuta, Tatsuya
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, May 2017, Vol.31(5), pp.1879-1890
13.
Ameliorating Effects of Sphingomyelin-Based Liposomes on Sarcopenia in Senescence-Accelerated Mice.
by Ishida, Yuuki
Biological & pharmaceutical bulletin, 2016, Vol.39(5), pp.786-793
14.
A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.
by Murase, Yuki
Cancer letters, January 28, 2010, Vol.287(2), pp.165-171
15.
Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs.
by Maeda, Noriyuki
Biological & pharmaceutical bulletin, September 2006, Vol.29(9), pp.1936-1940
16.
Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.
by Asai, Tomohiro
Cancer science, May 2008, Vol.99(5), pp.1029-1033
17.
Liposomalized oligopeptides in cancer therapy
by Asai, Tomohiro
Methods in enzymology, 2005, Vol.391, pp.163-76
18.
[Antineovascular gene therapy by Ago2 knockdown].
by Hatanaka, Kentaro
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, November 2008, Vol.128(11), pp.1567-1575
19.
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
by Kenjo, Eriya
Biological & pharmaceutical bulletin, 2013, Vol.36(2), pp.287-291
20.
Targeting and anti-tumor efficacy of liposomal 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma.
by Asai, T
Cancer letters, January 10, 2001, Vol.162(1), pp.49-56
